早期乳腺癌中Cathepsin D的表达及其预后和预测价值
Inas Alhudiri1,2, Christopher Nolan1, Ian Ellis1
1Breast Pathology Research Group, Nottingham Breast Cancer Research Centre, Biodiscovery Institute, Faculty of Medicine, The University of Nottingham, Nottingham, UK.
Breast cancer research and treatment
|April 5, 2024
概括
早期乳腺癌中甲素D的表达与预后较差和瘤特征更具侵略性有关. 建议进行进一步的研究,以探索其治疗潜力和与他莫西芬的相互作用.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 甲素D是一种溶解体酶,与乳腺癌的进展有关.
- 它在乳腺癌的预后和预测意义仍在争论中.
研究的目的:
- 为了研究Cathepsin D在乳腺癌早期阶段的表达.
- 评估其预后价值和与临床病理学参数的关联.
主要方法:
- 免疫组织化学染色被用来评估954名早期乳腺癌患者的Cathepsin D表达.
- 分析了与临床病理特征和患者结局的相关性.
主要成果:
- 在71.2%的瘤中表达了cathepsin D,并与更高等级,多形态和较差的NPI相关.
- 表达显着与复发率增加和远程转移相关.
- 在Cathepsin D表达下观察到更糟糕的乳腺癌特异性生存率的趋势.
结论:
- 甲素D表达是早期乳腺癌预后不佳的重要预测因子.
- 它与侵袭性瘤特征的关联表明,它有可能成为治疗点.
- 需要进一步调查Cathepsin D与ER阳性乳腺癌中tamoxifen的相互作用.
更多相关视频
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.0K
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.5K
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
